Drugdiscovery >> Drug Development >> News
4240
Views
Lilly's drug and Kadcyla were both turned down - drugdiscovery.com
Lilly's drug and Kadcyla were both turned down - drugdiscovery.com


Kadcyla unaffordable for NHS, Lilly's Alimta also turned down in NSCLC maintenance setting, but BI's Giotrif is approved for NSCLC subset
Read More >>


Tags: pharmatimes,pharma,news,pemetrexed,NICE,NHS,Giotrif,Roche ,Kadcyla,Alimta,breast cancer,NSCLC,afatinib,EGFR-TK,trastuzumab emtansine,CDF, - April 24, 2014
Related Articles
8376
Views
FDA asks for input on antibiotic drug discovery FDA asks for input on antibiotic drug discovery
A US Food and Drug Administration (FDA) taskforce working on advancing antibiotic drug development has outlined its initial areas of interest, and proposed a list of pathogens that could trigger exte Read More >>

Tags: antibiotic drug development, FDA, drug candidate

5385
Views
Electric controll of drug can prevent side-effects Electric controll of drug can prevent side-effects
Several drugs have side effects because they are active in those parts of the body where they should not be. A group of scientists created a "smart" implant, which might solve this problem. Read More >>

Tags: smart implant, scientists, side effects, drug development, electronic drug control

4792
Views
GSK's diabetes Drug got an FDA 'okay' GSK's diabetes Drug got an FDA 'okay'
Taneum, the diabetes drug of GSK has been given a green light by FDA. With this 'okay' sign the pharmaceutical company can enter new markets. Read More >>

Tags: pharmatimes,pharma news, Eperzan, approved, albiglutide, Tanzeum, GSK, drug development, pain, diabetes, diabetes drug, new treatment for diabetes.

7577
Views
SOLIAIR™ - Breathing Made Easy! SOLIAIR™ - Breathing Made Easy!
SOLIAIR™ is a blend of botanical extracts and a food supplement that can help patients in chronic respiratory diseases such as Asthma, Bronchitis, COPD and other respiratory infections! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

5559
Views
Orphan drug designation for DengueCide Orphan drug designation for DengueCide
FDA has approved orphan drug designation to DengueCide, NanoViricides’ drug candidate for the treatment of dengue and dengue hemorrhagic fever. Read More >>

Tags: DengueCide, dengue, hemorrhagic fever, drug,orphan drug, NanoViricides

2324
Views
Cytokinetics failed FDA's approval Cytokinetics failed FDA's approval
Cytokinetics' new ASÉ drug has failed clinical trials and was not approved by FDA. The drug has not reached the efficiency endpoint, therefore further research is going to be needed. Read More >>

Tags: drug, drug discovery, ASL drug, Cytokinetics asl drug, FDA approval, FDA approval of asl drugs.

10567
Views
New Pulmonary and Lung Diseases Solution! New Pulmonary and Lung Diseases Solution!
SOLIAIR™ is a food supplement which has reported beneficial impact. SOLIAIR™ can contribute to strengthening the respiratory system and may help patients in chronic respiratory diseases! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

5774
Views
The uncertain fate of the Orphan Drug Tax Credit The uncertain fate of the Orphan Drug Tax Credit
USA tax reform coming in the fall could lead to elimination of the Orphan Drug Tax Credit, which is given to pharmaceutical companies for development of drugs for rare diseases. Biotech companies have Read More >>

Tags: orphan drug tax credit, orphan drug development, orphan drug

2402
Views
Gilead has a new drug for HIV-1 infection Gilead has a new drug for HIV-1 infection
Gilead has announced that European Comission has accepted its new medicine, Vitekta. Te medicine includes ritonavir-boosted protease inhibitor - but what new things can it give to patients? Read More >>

Tags: patients, portease, drug, HIV

4328
Views
Sex drive drug for women is still missing Sex drive drug for women is still missing
Rebuilding sexaul desire of women is still a difficult question. A 65-year old women went through a clinical trial. She felt 20 years younger. However, there is something about this drug which slows t Read More >>

Tags: drug, process,

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013